Next-generation Water Systems in Pharma
Assessing the Merits of Agentic AI
Breaking Barriers in bioanalytical automation
Microbiological QC Bottlenecks in Biopharma
Why Pharma Products still go to Waste and How Better Logistics can Help
EDITORIAL SECTIONS
RESEARCH & DEVELOPMENT
Adopting the Power of AI to Drug Development Projects
A tremendous amount of documentation is created throughout the clinical trial lifecycle
CLINICAL TRIALS
Real-world Evidence
Hearing the diagnosis from the doctor that your child has spinal muscular atrophy SMA
MANUFACTURING
Just in Time Manufacturing Creating more sustainable supply chains
Drug development has transformed immeasurably over the past decade Even before the Covid pandemic and the conflict in Ukraine
Information Technology
Challenges and Advantages of Using Artificial Intelligence in Pharma
Many advanced largescale AI initiatives still need to be proved successful in Pharma
KNOWLEDGE BANK
Interviews
University of Lincoln, UK
Senior Lecturer, School of Pharmacy
Ishwar Singh is a Senior Lecturer in Biological Chemistry at the School of Pharmacy University of Lincoln Prior to Lincoln he had held many prestigious fellowships such as the Alexander von Humboldt fellowship Germany and Senior Research Fellowship DANIDA Denmark and CSIR India He is an organic chemist He has developed bioconjugations for DNA RNA and polymer modifications in water He is currently...
Articles
There’s Finally Hope to Alleviate the Burden of Chronic Diseases
As societies in Asia grow older chronic diseases are becoming more and more prevalent They place serious strain not only on patients but also on caregivers and the healthcare system
Research Insights
Partitioning stable and unstable expression level variation in cell populations: A theoretical framework and its application to the T cell receptor
Phenotypic variation in the copy number of gene products expressed by cells or tissues has been the focus of intense investigation To what extent the observed differences in cellular expression levels are persistent or transient is an intriguing question
Case Studies
Evaluation of A Sequencing Batch Reactor Sewage Treatment Rig For Investigating The Fate of Radioactively Labelled Pharmaceuticals: A Case Study of Propranolol
Abstract Pharmaceuticals are frequently detected in the aquatic environment and have potentially damaging effects Effluents from sewage treatment plants STPs are major sources of these substances The use of sequencing batch reactor SBR STPs involving cycling between aerobic and anoxic conditions to promote nitrification and denitrification is increasin
Techno Trends
Precigen Unveils 'First-and-Only' PAPZIMEOS™ (zopapogene imadenovec-drba) for the Treatment of Recurrent Respiratory Papillomatosis (RRP)
Precigen has introduced PAPZIMEOS zopapogene imadenovecdrba as the first and only FDAapproved treatment for adults with recurrent respiratory papillomatosis RRP a rare and potentially lifethreatening disease of the respiratory tract caused by chronic HPV or HPV infection
White Papers
Cloud Computing in the Laboratory Informatics Solutions and Validation Approaches
In the modern business environment, a significant portion of work is conducted using computerized systems. Many solutions are used to complete tasks, including simple desktop programs like email and Microsoft Office to enterprise-wide, global systems like ERP (Enterprise Resource Planning), MES (Manufacturing Execution System), and LIMS
TOP ARTICLES
Accelerating the Medical Writing Process with Automation From research to publication
Senior Associate, Medicinal Products Division, Freyr Solutions
Multi-Target Directed Ligands and Lipidomics Approach for Glioblastoma Drug Discovery
Department of Chemistry and Biochemistry, California State University, Fullerton, USA.
Department of Chemistry and Biochemistry, California State University, Fullerton, USA.
Department of Chemistry and Biochemistry, California State University, Fullerton, USA.
Faculty of Dentistry, University of Toronto, Toronto, Canada.
College of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba, Winnipewg, Manitoba, Canada.
Department of Medical Sciences, Institute of Biomedicine-iBiMED, University of Aveiro, Aveiro, Portugal.
Research Institute of Oncology and Hematology, Cancer Care Manitoba, University of Manitoba, Winnipeg, Canada.
How Ready are Cellulose Nanocrystals in Delivery of Anticanceragents?
Researcher, Donghua University
Perspectives on the Vaccine Industry
Senior Consultant, Process Solutions APAC, Life Science business sector of Merck
press releasesRead more...
Cleveland Clinic, RIKEN, and IBM Model a 12,635-Atom Protein - the Largest Known to Be Simulated with Quantum Computers
Scientists at Cleveland Clinic RIKEN and IBM NYSE IBM have used IBM quantum computers and two of the worlds most powerful supercomputers to simulate protein complexes spanning up to atoms
INmune Bio and Anthony Nolan Announce Strategic Expansion of CORDStrom™ MSC Platform Collaboration to Target RDEB, Oncology, and Inflammatory Diseases
INmune Bio Inc a clinicalstage biotechnology company and Anthony Nolan a pioneering UKbased charity that set up the worlds first stem cell register and is now driving forward cell therapy advancements
Cellenkos Announces FDA Clearance of Investigational New Drug (IND) Application for Phase 1b/ 2a Trial of CK0802 in Steroid-Refractory Graft-versus-Host Disease (GVHD)
Cellenkos Inc a clinical stage biotechnology company pioneering allogeneic tissuetargeted regulatory T cell Treg therapies today announced that the US Food and Drug Administration FDA has cleared its Investigational
European Commission (EC) Approves Henlius and Organon’s POHERDY® (pertuzumab), the First Approved Biosimilar to PERJETA (pertuzumab) in Europe
Shanghai Henlius Biotech Inc HK and Organon NYSE OGN today announced the European Commission EC has granted marketing authorization for POHERDY pertuzumab mg mL injection for intravenous use
Ecolab Life Sciences Expands Global Bioprocessing Capabilities With New Advanced Development and Applications Center in Korea
Building on the continued growth and strong performance of its Life Sciences business Ecolab is further expanding its global bioprocessing capabilities to support biopharmaceutical manufacturers worldwide
Samsung Bioepis and ATLATL Sign Memorandum of Understanding (MoU) to Accelerate Early-Stage Biotech Innovation in Asia-Pacific
Samsung Bioepis Co Ltd and ATLATL Innovation Center hereinafter referred to as ATLATL global innovation platform for life science research and development today announced that the companies have entered
EventsRead more...
05 - 06
May 2026GENAP Summit 2026
Vienna, Austria
06 - 07
May 202641th pharmacovigilance USA 2026
Boston, USA
06 - 07
May 20262nd Edition MaxPotent Pharma Summit 2026
Milan, Italy
07 - 08
May 202621st PPM for Pharma & Biotech
New Jersey, USA
10 - 14
May 2026Respiratory Drug Delivery 2026
The Westin Kierland Phoenix, Arizona, USA
12 - 13
May 2026PDA Pharmaceutical Manufacturing 2026
Singapore
14 - 14
May 2026PDA Microbiology in CCS Workshop 2026
Singapore
20 - 21
May 2026Pharmacovigilance Europe 2026
London, UK
LATEST NEWSRead more...
Merck Completes Acquisition of Terns Pharmaceuticals
Merck known as MSD outside the United States and Canada has completed the acquisition of Terns Pharmaceuticals
ZETA SURGICAL® Receives FDA 510(k) Clearance Expanding Access to Brain Tumor Biopsies, Hydrocephalus, and Trigeminal Neuralgia
Arrowhead Pharmaceuticals Inc has announced that Australias Therapeutic Goods Administration TGA has approved REDEMPLO plozasiran The medicine is a small interfering RNA siRNA therapy used alongside
CS Analytical Announces Major Laboratory Expansion
CS Analytical Laboratory has announced plans to expand its facility in Clifton New Jersey by doubling its current laboratory space The company is a cGMPcompliant FDAregistered and inspected contract laboratory focused on package and container
TLX101-Px (Pixlumi®) MAA Accepted in Europe
Telix Pharmaceuticals has announced that its marketing authorisation application MAA for TLXPx Pixlumi a brain cancer imaging candidate has been validated and accepted for review in Europe
TRUQAP recommended by FDA advisory panel for PTEN-deficient prostate cancer
US Food and Drug Administrations Oncologic Drugs Advisory Committee has supported the use of TRUQAP capivasertib in combination with abiraterone and androgen deprivation therapy ADT for patients
Evotec secures grants to advance tuberculosis treatment
Evotec SE has secured two new grants from the Bill Melinda Gates Foundation to support drug discovery and translational research in tuberculosis TB This follows four earlier TB grants from the foundation valued at million over months and million over months
